Research
OHE’s Deputy Director is Standing for the iHEA Board
7 November 2017
OHE’s Deputy Director Paula Lorgelly is standing as a candidate for the International Health Economics Association Board of Directors
Open Access Week 2017: Open in Order To…
25 October 2017
For Open Access Week 2017, the Office of Health Economics highlights its research publication archive dating back to 1962
What do Pharmaceuticals Really Cost in the Long Run?
6 October 2017
Drug prices in the US might overstate pharmaceuticals’ long-run cost up to 75%. True long-term costs then must be considered by market access and policy decisions.
OHE at the EuroQol Plenary Meeting 2017
26 September 2017
A summary of OHE researchers’ contributions to the 34th Plenary Meeting of the EuroQol Group in Barcelona.
OHE Lunchtime Seminar: The UK Biotech Sector and Brexit: Past Performance and Future Prospects
25 September 2017
OHE Lunchtime Seminar with Sir Geoffrey Owen and Professor Michael Hopkins. The biotech sector of the US has enjoyed a success that the UK sector has…
What Determines Health Care Expenditure in High Income Countries?
18 September 2017
OHE’s Yan Feng and Grace Hampson, along with colleagues from the Health Foundation and RAND Europe, have published a new paper in Applied Economics and Finance…
Presentation at the NHS Global Health Volunteering Group Meeting: “The Value of International Volunteering and Placements to the NHS”
13 September 2017
OHE presented at the NHS Global Health Volunteering Group meeting in London on research measuring the value of international volunteering for the NHS.
A New Valuation Method: Directly Eliciting Personal Utility Functions
30 August 2017
A new OHE Research Paper describes a novel approach for valuing health-related quality of life: directly eliciting personal utility functions
An Update on the EQ-5D-5L Value Set for England
22 August 2017
In this blog we (1) summarise the current status of the EQ-5D-5L value set for England; (2) highlight NICE’s recent statement on the values to be…